Results 151 to 160 of about 950,753 (317)

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Ranking of employees' reward and recognition approaces: A Malaysian Perspective

open access: yes
Recognition of employees’ achievements is one of the most important factors to motivate employees. Employees who perform exceptionally well, expect that their contributions will be recognized or they will be appreciated by the top management.
Ismail, Ahmad Zaki, Islam, Rafikul
core  

Other title: How-to Guide for Designated Agents

open access: yes, 2008
"Revised 11/08".; application/pdfWe're Here to Help Eligible Employees Plan Overview Enrollment and When Coverage Begins Applying for Coverage Life Insurance Report and Deducting Premiums If You Overpaid or Underpaid (Refunds and Arrearages ...
Kansas Public Employees Retirement System.
core  

Employee Engagement and Employee Voice [PDF]

open access: yesInternational Journal of Academic Research in Progressive Education and Development, 2018
Nur Zahidah Abdul Latif   +1 more
openaire   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Employee preferences in health plan design: results from a national survey. [PDF]

open access: yesHealth Aff Sch
Kaplan RM   +4 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy